While some studies have looked into the expression and significance of IGF2BP3 in breast cancer (10–15), a comprehensive understanding of its clinical use and diagnostic value in this type of cancer has not been reached, possibly due to limited sample sizes in some studies or insufficient comprehensive clinicopathological correlation analyses. This evidence concerns the gene IGF2BP3 and cancer.